We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 20 JANUARY 2011
Biosimilars, "Bolar Exception" and Data Exclusivity Under Turkish Law
Selçuk | Gündüz
Biosimilars are defined under the Communiqué on Pricing of Medicinal Products for Human Use as medicines that (i) are similar to and hold the same strength with licensed original biological medicines, (ii) are used to treat the same diseases as the original product, and (iii) are not generic.
TurkeyIntellectual Property






